colfax_m
Diamond Member
- Nov 18, 2019
- 38,988
- 14,843
- 1,465
That problem makes this paper’s interpretation garbage.Yeah, there’s a problem with that. The idea that you’re only treating the “early” patients means that the risk of that specific group is already far lower than average.The key to testing these substances is EARLY treatment, as soon as a positive test is shown, a fact which continually appears to go over your head.
OF COURSE.
So your solution is to treat nobody?
My solution is to not use drugs that have no efficacy.